Bone Marrow Transplants, Other Therapies, and Sickle Cell Disease

This webinar highlights research findings from various NHLBI-funded studies and evaluates bone marrow transplant therapies for sickle cell disease. This video is by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Learn more: https://www.nhlbi.nih.gov/grants-and-training Follow us on Twitter: http://www.twitter.com/nih_nhlbi Like us on Facebook: http://www.facebook.com/NHLBI

Science

National Heart, Lung, and Blood Institute

Website

https://www.nhlbi.nih.gov

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.

Core Mission Areas

The Science

Discover the goals, challenges, and initiatives that have shaped and will continue to shape prevention, diagnosis, and treatment for the NHLBI’s scientific focus areas.

Clinical Trials

NHLBI-funded clinical trials look at new ways to prevent, detect, or treat disease. The NHLBI is also focused on management and oversight of these trials.